Magnolia Medical Technologies
4 known investors
Magnolia Medical develops the Steripath® platform, an FDA-cleared medical device designed to reduce blood culture contamination and improve diagnostic accuracy for sepsis testing in hospital settings. The solution is used by hospitals and healthcare systems to enhance clinical decision-making and patient outcomes.
Digital HealthHealthtechMedical Devices
Investors · 4
In the news
- Sell or Invest in Magnolia Medical Technologies Stock Pre-IPOnasdaqprivatemarket.com · 2025
- Magnolia Medical raises $46m for Steripath platformnsmedicaldevices.com · 2022
- Seattle biotech Magnolia Medical raises $46M - Puget Sound Business Journalbizjournals.com · 2022
- Reducing contamination during blood tests: Magnolia Medical lands $46M to fuel growth – GeekWiregeekwire.com · 2022
- Magnolia Medical Raises $20M in Series C Financing - FinSMEsfinsmes.com · 2019
- Magnolia Medical raises $13.8m - MassDevicemassdevice.com · 2016